Denosumab in Giant Cell Rich Tumors of Bone: An Open-Label Multicenter Phase II Study

Astrid Lipplaa, Willem H. Schreuder, Sarina E.C. Pichardo, Hans Gelderblom*

*Corresponding author for this work

Research output: Contribution to Journal › Article › Academic › peer-review

Fingerprint

Dive into the research topics of 'Denosumab in Giant Cell Rich Tumors of Bone: An Open-Label Multicenter Phase II Study'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry

Immunology and Microbiology